Clinical trials
Intubation; Difficult or Failed clinical trials
Below are recruiting intubation; difficult or failed clinical trials, each written for real people, not researchers. We’re tracking 152 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06881589Recruiting
Using ultrasound and exams to guide breathing tube placement
This study tests if using ultrasound with routine checks can better predict the best way to place a breathing tube during surgery. It aims to make intubation safer and more successful.
Madrid, MadridAges 18–90 - NCT06839066RecruitingPhase 2
HLX43 for advanced nasopharyngeal cancer after prior treatments
This trial tests an investigational drug called HLX43 for people with nasopharyngeal cancer that has come back or spread, and who have already tried two or more prior treatments without success. The goal is to see if HLX43 can shrink tumors or slow the cancer's growth.
Fuzhou, FujianAges 18 years+ - NCT06817720RecruitingPhase 2
Olverembatinib for newly diagnosed chronic phase CML
This trial tests the drug olverembatinib alone for people with newly diagnosed chronic phase CML who have not had much prior treatment. It aims to see how well the drug works and what side effects it may cause.
Houston, TexasAges 18 years+ - NCT06799637RecruitingPhase 1/Phase 2
Study of XNW28012 for advanced solid tumors
This trial tests a new drug called XNW28012 for people with advanced solid tumors that have not responded to or caused side effects from standard treatments. It aims to see if the drug can shrink tumors or slow their growth.
Hefei, AnhuiAges 18 years+ - NCT06769113RecruitingPhase 2
Study of HLX43 for advanced esophageal cancer
This trial tests a new drug, HLX43, for people with advanced esophageal squamous cell carcinoma that has stopped responding to or cannot tolerate standard treatments. It aims to see if HLX43 can help shrink or control the cancer.
Jinan, ShandongAges 18–75 - NCT06762964RecruitingPhase 2
Dapagliflozin for Failing Fontan Circulation
This study tests whether a medication called dapagliflozin (a pill for heart failure) can help people with a Fontan circulation who feel short of breath. It aims to improve symptoms and quality of life.
Rochester, MinnesotaAges 18 years+ - NCT05303896Recruiting
Study changes in remodeling heart tissue before transplant
This study looks at how the heart’s structure changes (“remodeling”) in people with heart failure who are being considered for a heart transplant. It may help doctors better understand what is happening in the failing heart and how to treat it.
Oslo, OsloAges 18–100 - NCT06374485RecruitingPhase 1
AU409 capsule for advanced liver cancer after other treatments fail
This trial tests a new capsule called AU409 for people with advanced liver cancer (HCC) who have already tried standard treatments and they no longer work. The goal is to see if AU409 can help control the cancer.
Hong KongAges 18–75 - NCT06527664Recruiting
Custom hip implant for failed arthritis treatments
This trial tests a custom-made hip socket implant for people who have had a failed hip replacement or arthritis treatment. It aims to see if a personalized implant can provide a better solution.
BolognaAges 18 years+ - NCT06508723Enrolling by invitation
Comparing dental implants with different surfaces
This study tests two types of dental implant surfaces to see which works better. It may be a good fit if you need one or more missing teeth replaced and are generally healthy.
KütahyaAges 18–99 - NCT06351904RecruitingPhase 1
Testing RAG-01 for bladder cancer that returned after BCG treatment
This trial tests a new drug, RAG-01, for people with a type of bladder cancer called non-muscle-invasive bladder cancer (NMIBC) that has come back after BCG therapy. The drug is given through a catheter into the bladder, and the study aims to see if it can help control the cancer.
St Leonards, New South WalesAges 18–75 - NCT06430268Enrolling by invitation
Cleaning methods for infected dental implants
This study is testing different ways to clean a dental implant that is failing due to severe infection (peri-implantitis). If you need to have an implant removed because of advanced bone loss, the researchers will compare cleaning methods during the removal procedure.
Pittsburgh, PennsylvaniaAges 18–80 - NCT05608772Recruiting
Revision weight-loss surgery after failed sleeve
This study looks at which revision surgery works best after a prior sleeve stomach operation that didn’t last. It tests switching to one of three procedures to help with weight regain, and it excludes more severe acid reflux cases.
Alexandria, Alexandria GovernorateAges 18–60 - NCT05754190Recruiting
Smartphone study of mood and symptoms in people with pain
This study uses a smartphone app to track daily pain and mood changes over about 4 months. It’s meant to learn patterns that could help better understand how mood and pain affect each other.
Providence, Rhode IslandAges 18 years+ - NCT06368388Recruiting
Personalized phage therapy for hard-to-treat infections
This trial studies using phages (viruses that attack bacteria) to treat infections that have not improved with other treatments. It aims to see if this patient-specific approach works and what it costs.
LeuvenAges Any age - NCT06343805RecruitingPhase 1
Study of LY5830966 for myelofibrosis after JAK inhibitor treatment
This study tests a new drug called LY5830966 for people with myelofibrosis whose disease has not responded to or has returned after treatment with a type I JAK2 inhibitor. The drug aims to help reduce symptoms and improve outcomes.
Palo Alto, CaliforniaAges 18 years+ - NCT06295432RecruitingPhase 2
Study of two targeted drugs for EGFR-mutated lung cancer
This trial tests a combination of two targeted drugs (DZD9008 and AZD4205) for people with advanced non-small cell lung cancer that has a specific EGFR mutation and has stopped responding to standard treatments. The goal is to see if this combination can shrink tumors or slow cancer growth.
Guangzhou, GuangdongAges 18 years+ - NCT06220162RecruitingPhase 2
VAC Regimen for AML Not Responding to VA
This trial tests a new drug combination (VAC) for people with acute myeloid leukemia (AML) who did not improve after standard VA treatment. It is for those who cannot have strong chemotherapy due to age or health problems.
Suzhou, JiangsuAges 18–80 - NCT05269212Recruiting
Help people with ongoing back pain return to work
This study looks at how to help people with long-lasting spinal pain (PSPS-Type II) get back to work. It may help by testing a plan for managing persistent pain so work becomes more doable.
GhentAges 18–60 - NCT06099717Recruiting
Testing a two-tooth dental bridge on one implant
This study tests if a special bridge supported by a single implant can replace three missing back teeth. It may help people who have a large enough jawbone and good overall health.
Goiânia, GoiásAges 18 years+ - NCT05926700RecruitingPhase 2
Testing cadonilimab plus anlotinib for advanced soft tissue sarcoma
This Phase 2 study tests two medicines (cadonilimab and anlotinib) in people with advanced soft tissue sarcoma whose cancer grew after standard first treatment. It aims to see whether the combination can shrink tumors and improve safety.
HangzhouAges 18 years+ - NCT05915663Recruiting
Choosing where to place a stomach tube
This study looks at whether different placement locations for a stomach (gastric) tube can lower the risk of pneumonia in people on a breathing machine. It’s aimed at patients expected to need ventilation for more than 48 hours.
AngersAges 18 years+ - NCT05857696Recruiting
Spinal Stimulation to Improve Walking in Chronic Back and Leg Pain
This pilot study tests whether a special spinal cord stimulator—a small device that sends gentle electrical signals to your spinal cord—can help you walk better if you have ongoing nerve pain in your lower back and leg after spine surgery. The goal is to reduce pain and improve your ability to move around.
NiceAges 18–70 - NCT05809284Recruiting
Understanding CAR T-cell therapy persistence in young patients with ALL
This study looks at why CAR T-cell therapy stops working in some children and young adults with leukemia. It aims to help doctors understand how to make this treatment last longer.
LondonAges Up to 25 years
Hear when a new Intubation; Difficult or Failed trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for intubation; difficult or failed?
- Yes. Clin2 currently lists 152 recruiting intubation; difficult or failed studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a intubation; difficult or failed trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a intubation; difficult or failed trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.